Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Treatment-resistant Schizophrenia”

158 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 158 results

Not applicableStudy completedNCT00512070
What this trial is testing

Melatonin Metabolism Abnormality in Patients With Schizophrenia or Schizoaffective Disorder Treated With Olanzapine

Who this might be right for
SchizophreniaSchizoaffective DisorderBipolar Disorder+2 more
Seattle Institute for Biomedical and Clinical Research 40
Not applicableUnknownNCT04352569
What this trial is testing

Efficacy of tDCS in the Treatment of Resistant Auditory Hallucinations in Schizophrenia

Who this might be right for
SchizophreniaHallucinationsRefractory Schizophrenia
Centre hospitalier de Ville-Evrard, France 44
Not applicableUnknownNCT01879956
What this trial is testing

Occupational Therapy in the Rehabilitation of Executive Functions in Patients With Schizophrenia

Who this might be right for
Refractory Schizophrenia
University of Sao Paulo 60
Not applicableStudy completedNCT03409393
What this trial is testing

Feasibility and Relevance of High-Intensity Functional Training in Patients With First-Episode Psychosis

Who this might be right for
SchizophreniaSchizotypal DisorderFirst Episode Psychosis+2 more
Rigshospitalet, Denmark 27
Post-approval studies (Phase 4)UnknownNCT03708549
What this trial is testing

Comparison of Berberine and Metformin for the Treatment for MS in Schizophrenia Patients

Who this might be right for
SchizophreniaMetabolic SyndromeBerberine+1 more
Tianjin Anding Hospital 100
Large-scale testing (Phase 3)Ended earlyNCT00216281
What this trial is testing

Efficacy and Safety Study of Clozapine Augmented by Atomoxetine Versus Clozapine Augmented by Placebo in Patients With Chronic Resistant Schizophrenia

Who this might be right for
Schizophrenia
Indiana University 126
Post-approval studies (Phase 4)Ended earlyNCT00947375
What this trial is testing

Lamictal TM, Haloperidol Decanoate in Schizophrenia

Who this might be right for
Schizophrenia
Central Mental Clinic for Outpatients of Baku City 335
Not applicableStudy completedNCT00345982
What this trial is testing

Augmenting Clozapine With Sertindole - SERCLOZ

Who this might be right for
Schizophrenia
University of Aarhus 50
Not applicableNot Yet RecruitingNCT07445620
What this trial is testing

Comparison of Accelerated Intermittent Theta Burst Stimulation vs High Frequency Transcranial Magnetic Stimulation (Hf-rTMS) on Cognitivesymptoms in Treatment-resistant Schizophrenia

Who this might be right for
PsychosisSchizophrenia Disorder
All India Institute of Medical Sciences, Bhubaneswar 90
Large-scale testing (Phase 3)Looking for participantsNCT03094429
What this trial is testing

An Adaptive Phase II/III, Two-Part, Double-Blind, Randomized, Placebo-controlled, Dose-Finding, Multi-center Study of the Safety and Efficacy of NaBen®, as an Add-on Therapy With Clozapine, for Residual Symptoms of Refractory Schizophrenia in Adults

Who this might be right for
Refractory Schizophrenia
SyneuRx International (Taiwan) Corp 287
Post-approval studies (Phase 4)Study completedNCT00231894
What this trial is testing

Pioglitazone as a Treatment for Lipid and Glucose Abnormalities In Patients With Schizophrenia

Who this might be right for
DiabetesSchizophreniaInsulin Resistance+1 more
Nathan Kline Institute for Psychiatric Research 56
Testing effectiveness (Phase 2)Looking for participantsNCT04887792
What this trial is testing

Acetazolamide for Treatment Resistant Schizophrenia

Who this might be right for
SchizophreniaSchizo Affective Disorder
Vishwajit Nimgaonkar, MD PhD 60
Not applicableLooking for participantsNCT06749444
What this trial is testing

Cognitive Behavioral Therapy for Sleep and Circadian Disturbances (CBT-I) in Treatment-Resistant Schizophrenia

Who this might be right for
Treatment-refractory SchizophreniaTreatment-resistant Schizophrenia
Jimmi Nielsen 60
Post-approval studies (Phase 4)Study completedNCT01105481
What this trial is testing

Amisulpride Augmentation Therapy for Clozapine-resistant Schizophrenic Patients

Who this might be right for
Treatment-resistant Schizophrenia
National Health Research Institutes, Taiwan 273
Post-approval studies (Phase 4)Study completedNCT02124811
What this trial is testing

Minocycline Augmentation to Clozapine

Who this might be right for
SchizophreniaSchizoaffective Disorder
Emory University 10
Not applicableUnknownNCT01300637
What this trial is testing

Effects of Adjunctive Metformin on Metabolic Profiles in Clozapine-treated Schizophrenic Patients

Who this might be right for
ObesityMetabolic SyndromeSchizophrenia
Taipei Medical University WanFang Hospital 60
Not applicableStudy completedNCT02377505
What this trial is testing

Deep Brain Stimulation in Treatment Resistant Schizophrenia

Who this might be right for
Refractory Schizophrenia
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 8
Not applicableUnknownNCT02159001
What this trial is testing

Electroconvulsive Therapy in Clozapine-resistant Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective Disorder
Niuvanniemi Hospital 20
Testing effectiveness (Phase 2)Study completedNCT02532686
What this trial is testing

DAAOI-2 add-on Treatment for Treatment-resistant Schizophrenia

Who this might be right for
Schizophrenia
China Medical University Hospital 40
Not applicableEnded earlyNCT02361554
What this trial is testing

Deep Brain Stimulation in Treatment Resistant Schizophrenia

Who this might be right for
Treatment-resistant Schizophrenia
Johns Hopkins University 15
Load More Results